A 10-Year-old Girl with Late Acute Lymphoblastic Leukemia Recurrence Diagnosed with COVID-19 and Treated with Remdesivir

Justyna Gadzińska, Ernest Kuchar, Michał Matysiak, Monika Wanke-Rytt, Malgorzata Kloc, Jacek Z. Kubiak

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Patients with hemato-oncologic diseases are particularly vulnerable to severe infections. Adult patients with blood cancers infected with SARS-CoV-2 had poorer treatment outcomes and higher mortality than patients with COVID-19 without burden. However, in pediatric patients with hemato-oncologic diseases the course of COVID-19 is milder than in adults in the same group of patients. In this report, we describe the case of our patient with acute lymphoblastic leukemia infected with SARS-CoV-2 and treated with remdesivir. We also review the existing literature of pediatric patients who have been diagnosed with both hemato-oncologic diseases and COVID-19.

Original languageEnglish (US)
Pages (from-to)E537-E538
JournalJournal of pediatric hematology/oncology
Volume44
Issue number2
DOIs
StatePublished - Mar 1 2022

Keywords

  • COVID-19
  • SARS-CoV-2
  • acute lymphoblastic leukemia
  • pediatrics
  • remdesivir
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications
  • COVID-19 Drug Treatment
  • Prognosis
  • COVID-19/complications
  • SARS-CoV-2/isolation & purification
  • Alanine/analogs & derivatives
  • Humans
  • Adenosine Monophosphate/analogs & derivatives
  • Neoplasm Recurrence, Local/drug therapy
  • Antiviral Agents/therapeutic use
  • Female
  • Child

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'A 10-Year-old Girl with Late Acute Lymphoblastic Leukemia Recurrence Diagnosed with COVID-19 and Treated with Remdesivir'. Together they form a unique fingerprint.

Cite this